Zhi Tong Cai Jing·2026-01-29 09:53Core Viewpoint - The company, Zhaoyan New Drug (603127), announced a share reduction plan by its actual controller, Zhou Zhiwen, which involves selling up to 14.98 million shares, representing 20.0466% of his holdings and 1.99873% of the company's total share capital [1] Summary by Relevant Sections - Share Reduction Plan: Zhou Zhiwen disclosed a plan to reduce his holdings starting from December 30, 2025, allowing for a period of three months post-announcement to sell shares through the Shanghai Stock Exchange [1] - Execution of the Plan: As of January 29, 2026, Zhou Zhiwen successfully reduced his holdings by 14.979 million shares through block trades and competitive bidding, and subsequently decided to terminate the reduction plan ahead of schedule [1]